4
Changes in Ownership
Royalty Pharma plc Filed Acc 0001802768-23-000032
EVP, Investments & CLO acquired 150,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lloyd George W. EVP, Investments & CLO | 2023-11-13 | Conversion | +50,000 | 80,000 | I: show line 1 in the form | ||
| Lloyd George W. EVP, Investments & CLO | 2023-11-13 | Conversion | +100,000 | 220,000 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lloyd George W. EVP, Investments & CLO | 2023-11-13 | Conversion · LP interests in RPI US Partners 2019, LP | −5,000 | 245,299 | I: show line 3 in the form | ||
| Lloyd George W. EVP, Investments & CLO | 2023-11-13 | Conversion · LP interests in RPI US Partners 2019, LP | −10,000 | 162,680 | I: show line 4 in the form |
Loading xslF345X05/wk-form4_1700008499.xml…